Prot #D5180C00032: A Multicenter, Single‐arm, Open‐label, Post‐Authorization, Phase 4 Effectiveness and Safety Study of Tezepelumab in Adult and Adolescent Participants with Uncontrolled Asthma including Several Under‐Studied Populations in the United Sta

Project: Research project

Project Details

StatusActive
Effective start/end date10/4/22 → 10/3/27

Funding

  • Parexel (Prot #D5180C00032 // Prot #D5180C00032)
  • AstraZeneca Pharmaceuticals LP (Prot #D5180C00032 // Prot #D5180C00032)